atropine has been researched along with Diabetic Retinopathy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Novack, GD | 1 |
| Brooks, RA; Burrin, JM; Hyer, SL; Kohner, EM; Sharp, PS | 1 |
1 trial(s) available for atropine and Diabetic Retinopathy
| Article | Year |
|---|---|
Failure to suppress GH secretion after 2 weeks treatment with atropine or propanthelene in diabetics with proliferative retinopathy.
Topics: Adult; Atropine; Blood Glucose; Diabetic Retinopathy; Female; Growth Hormone; Humans; Male; Middle Aged; Propantheline; Receptors, Muscarinic | 1988 |
1 other study(ies) available for atropine and Diabetic Retinopathy
| Article | Year |
|---|---|
Eyes on New Product Development.
Topics: Atropine; Clinical Trials as Topic; Diabetic Retinopathy; Drug Industry; Eye Diseases; Humans; Macular Degeneration; Macular Edema; Ophthalmic Solutions | 2018 |